NCT04820803View on ClinicalTrials.gov

Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

April 29, 2021

Study Completion Date

June 30, 2021

Conditions
COVID-19SARS-CoV-2 Infection
Interventions
OTHER

ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE

one mouthwash containing cetylpyridinium chloride (0.07%) for 60 seconds

OTHER

PLACEBO

one mouthwash containing distilled (placebo) water for 60 seconds

Trial Locations (1)

50009

Seminario Health Center and Lozano Blesa University Clinical Hospital, Zaragoza

All Listed Sponsors
collaborator

Dentaid SL

INDUSTRY

lead

Rosa Tarrago

OTHER

NCT04820803 - Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19 | Biotech Hunter | Biotech Hunter